Association of Estrogen in the Risks of Parkinson’s Disease in South Korean Women
DOI:
https://doi.org/10.47611/jsrhs.v13i3.6918Keywords:
South Korea, Women, Estrogen, Oral Contraceptives, Hormone replacement therapy, Menopause, Parkinson's disease, Reproductive lifeAbstract
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the death of neurons, resulting in symptoms such as shaking, stiffness, and impaired balance. Research suggests a potential link between estrogen, a female sex hormone, and PD risk, with studies indicating that estrogen may play a protective role against the disease. However, most research on this topic has been conducted on European populations, leaving the role of estrogen in PD risk among Asian women, particularly in South Korea, unclear.
This study contributes to understanding the potential protective role of estrogen in PD by focusing on South Korean women. A case-control study design was employed, comparing responses from women with PD to healthy controls. The study investigated various reproductive life events, including menstruation, menopause, and hormone replacement therapy, using a questionnaire administered to participants in South Korea.
Results revealed that PD patients were significantly older than controls, with differences in reproductive lifespan and age at menopause. Women who underwent surgical menopause showed an increased risk of PD, while hormone replacement therapy and oral contraceptive usage did not show consistent associations with PD risk. The study concludes that estrogen is neither a protective nor a risk factor for PD in South Korean women.
This research contributes to the understanding of PD risk factors among South Korean women and highlights the need for further exploration into non-genetic gender-specific symptoms and societal influences on PD risk, aiming to reduce underrepresentation and medical discrimination in PD research.
Downloads
References or Bibliography
Ali, N., Sohail, R., Jaffer, S. R., Siddique, S., Kaya, B., Atowoju, I., Imran, A., Wright, W., Pamulapati, S., Choudhry, F., Akbar, A., & Khawaja, U. A. (2023). The Role of Estrogen Therapy as a Protective Factor for Alzheimer’s Disease and Dementia in Postmenopausal Women: A Comprehensive Review of the Literature. Cureus, 15(8), e43053. https://doi.org/10.7759/cureus.43053
Appiah, D., Nwabuo, C. C., Ebong, I. A., Wellons, M. F., & Winters, S. J. (2021). Trends in Age at Natural Menopause and Reproductive Life Span Among US Women, 1959-2018. JAMA, 325(13), 1328–1330. https://doi.org/10.1001/jama.2021.0278
Benedetti, M., Maraganore, D., Bower, J., McDonnell, S., Peterson, B., Ahlskog, E., Schaid, D., & Rocca, W. (2001, October 12). Hysterectomy, menopause, and estrogen use preceding Parkinson’s disease: An exploratory case‐control study. International Parkinson and Movement Disorder Society. https://doi.org/10.1002/mds.1170
Cerri, S., Mus, L., & Blandini, F. (2019). Parkinson’s Disease in Women and Men: What’s the Difference? Journal of Parkinson’s Disease, 9(3), 501–515. https://doi.org/10.3233/JParkinson's disease-191683
Cooper, D. B., Patel, P., & Mahdy, H. (2024). Oral Contraceptive Pills. In StatPearls. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK430882/
Criado-Perez, C. (2021). Invisible women: Data bias in a world designed for men. Abrams Press.
Currie, L., Harrison, M., Trugman, J., Bennett, J., & Wooten, F. (2004, June). Postmenopausal Estrogen Use Affects Risk for Parkinson Disease. JAMA Neurology Network. https://jamanetwork.com/journals/jamaneurology/fullarticle/786007
Duke University Health System. (2018, March 30). Neurology and Women’s Health, Part 5: Parkinson’s and Movement Disorders. Neurology and Women’s Health, Part 5: Parkinson’s and Movement Disorders. https://neurology.duke.edu/news/neurology-and-womens-health-part-5-parkinsons-and-movement-disorders
Gaenslen, A., Swid, I., Liepelt-Scarfone, I., Godau, J., & Berg, D. (2011). The patients’ perception of prodromal symptoms before the initial diagnosis of Parkinson’s disease. Movement Disorders, 26(4), 653–658. https://doi.org/10.1002/mds.23499
Gandhi, K. R., & Saadabadi, A. (2024). Levodopa (L-Dopa). In StatPearls. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK482140/
García-Ramos, R., Santos-García, D., Alonso-Cánovas, A., Álvarez-Sauco, M., Ares, B., Ávila, A., Caballol, N., Carrillo, F., Escamilla Sevilla, F., E. Freire, Gómez Esteban, J. C., Legarda, I., López Manzanares, L., López Valdés, E., Martínez-Torres, I., Mata, M., Pareés, I., Pascual-Sedano, B., Mir, P., & Martínez Castrillo, J. C. (2021). Management of Parkinson’s disease and other movement disorders in women of childbearing age: Part 1. Neurología (English Edition), 36(2), 149–157. https://doi.org/10.1016/j.nrleng.2020.05.015
Gong, D. K. (n.d.). Intro | “If you lie down you die, if you walk you live.” Korean Parkinson’s Disease Association. Retrieved October 19, 2023, from http://www.kpda.co.kr/
Hatcher, R. (2018). Contraceptive Technology (21st ed.). Ayer Company Publishers, Incorporated. https://books.google.com/books/about/Contraceptive_Technology.html?id=qsz8twEACAAJ
Hunley, K. L., Healy, M. E., & Long, J. C. (2009). The global pattern of gene identity variation reveals a history of long-range migrations, bottlenecks, and local mate exchange: Implications for biological race. American Journal of Physical Anthropology, 139(1), 35–46. https://doi.org/10.1002/ajpa.20932
Johns Hopkins Medicine. (2023, October 13). Young-Onset Parkinson’s Disease. Johns Hopkins Medicine. https://www.hopkinsmedicine.org/health/conditions-and-diseases/parkinsons-disease/youngonset-parkinsons-disease
Kenborg, L., Lassen, C. F., Ritz, B., Andersen, K. K., Christensen, J., Schernhammer, E. S., Hansen, J., Wermuth, L., Rod, N. H., & Olsen, J. H. (2015). Lifestyle, Family History, and Risk of Idiopathic Parkinson Disease: A Large Danish Case-Control Study. American Journal of Epidemiology, 181(10), 808–816. https://doi.org/10.1093/aje/kwu332
Kenton, W. (2023, June 28). Goodness-of-Fit. Investopedia. https://www.investopedia.com/terms/g/goodness-of-fit.asp
Kim, A., & Woo, K. (2022). Gender differences in the relationship between informal caregiving and subjective health: The mediating role of health promoting behaviors. BMC Public Health, 22(1), 311. https://doi.org/10.1186/s12889-022-12612-3
Kim, H.-Y. (2017). Statistical notes for clinical researchers: Chi-squared test and Fisher’s exact test. Restorative Dentistry & Endodontics, 42(2), 152–155. https://doi.org/10.5395/rde.2017.42.2.152
Kim, H., Jung, J. H., Han, K., Lee, D.-Y., Fava, M., Mischoulon, D., & Jeon, H. J. (2023). Ages at menarche and menopause, hormone therapy, and the risk of depression. Science Direct, 83, 35–42.
Kim, S., Park, H.-J., Park, M. J., & Kim, H. S. (2020). Reliability and Validity of the Korean Short-form Eight-item Parkinson’s Disease Questionnaire (Parkinson's diseaseQ-8). Journal of Health Informatics and Statistics, 45(2), 147–156. https://doi.org/10.21032/jhis.2020.45.2.147
Kittles, R. A., & Weiss, K. M. (2003). Race, Ancestry, and Genes: Implications for Defining Disease Risk. Annual Review of Genomics and Human Genetics, 4(1), 33–67. https://doi.org/10.1146/annurev.genom.4.070802.110356
Kompoliti, K., Comella, C. L., Jaglin, J. A., Leurgans, S., Raman, R., & Goetz, C. G. (2000). Menstrual-related changes in motoric function in women with Parkinson’s disease | Neurology [November 28, 2000]. Neurology Journals. Retrieved December 5, 2023, from https://doi.org/10.1212/WNL.55.10.1572
KPDA. (2023, October 11). 여의도 국회의사당 집회—YouTube. https://www.youtube.com/watch?v=ogE-GVELcAg
Latif, S., Jahangeer, M., Razia, D., Ashiq, M., Ghaffar, A., Akram, M., Allam, A., Bouyahya, A., Garipova, L., Shariati, M., Thiruvengadam, M., & Ansari, M. (2021, June 21). Dopamine in Parkinson’s disease—ScienceDirect. Science Direct. https://doi.org/10.1016/j.cca.2021.08.009
Liu, R., Baird, D., Park, Y., Freedman, N. D., Huang, X., Hollenbeck, A., Blair, A., & Chen, H. (2014). Female reproductive factors, menopausal hormone use, and Parkinson’s disease. Movement Disorders, 29(7), 889–896. https://doi.org/10.1002/mds.25771
Lv, M., Zhang, Y., Chen, G.-C., Li, G., Rui, Y., Qin, L., & Wan, Z. (2017). Reproductive factors and risk of Parkinson’s disease in women: A meta-analysis of observational studies. Behavioural Brain Research, 335, 103–110. https://doi.org/10.1016/j.bbr.2017.07.025
Maffoni, M., Giardini, A., Pierobon, A., Ferrazzoli, D., & Frazzitta, G. (2017). Stigma Experienced by Parkinson’s Disease Patients: A Descriptive Review of Qualitative Studies. Hindawi, 2017, 7. https://doi.org/10.1155/2017/7203259
Marras, C., & Saunders-Pullman, R. (2014). The Complexities of Hormonal Influences and Risk of Parkinson’s Disease. Movement Disorders : Official Journal of the Movement Disorder Society, 29(7), 845–848. https://doi.org/10.1002/mds.25891
Mayo Clinic. (2023, May 26). Parkinson’s disease—Symptoms and causes. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/parkinsons-disease/symptoms-causes/syc-20376055
McKinney, K., Hinshaw, K., Ross, D., Whitehead, M., Stevenson, J., Panico, S., Galasso, R., Celentano, E., Frova, L., Capocaccia, R., & Berrino, F. (1996). Use Of Hormone Replacement Therapy. BMJ: British Medical Journal, 313(7058), 686–687.
Michael J. Fox Foundation. (n.d.). Sexual & Reproductive Health | Parkinson’s Disease. The Michael J. Fox Foundation for Parkinson’s Research. Retrieved February 20, 2024, from https://www.michaeljfox.org/news/sexual-reproductive-health
Morris, M. (2001). GENDER-SENSITIVE HOME AND COMMUNITY CARE AND CAREGIVING RESEARCH: A SYNTHESIS PAPER. Health Canada Women’s Health Bureau, 88.
National Health Service. (2022, October 11). Hysterectomy. Nhs.Uk. https://www.nhs.uk/conditions/hysterectomy/
National Institute of Standards and Technology. (n.d.). 1.3.6.6.18. Binomial Distribution. National Institute of Standards and Technology. Retrieved February 20, 2024, from https://www.itl.nist.gov/div898/handbook/eda/section3/eda366i.htm
National Institute on Aging. (2022, April 14). Parkinson’s Disease: Causes, Symptoms, and Treatments. National Institute on Aging. https://www.nia.nih.gov/health/parkinsons-disease/parkinsons-disease-causes-symptoms-and-treatments
Nicoletti, A., Nicoletti, G., Arabia, G., Annesi, G., De Mari, M., Lamberti, P., Grasso, L., Marconi, R., Epifanio, A., Morgante, L., Cozzolino, A., Barone, P., Quattrone, A., & Zappia, M. (2011). Reproductive factors and Parkinson’s disease: A multicenter case–control study. Movement Disorders, 26(14), 2563–2566. https://doi.org/10.1002/mds.23951
Nitkowska, M., Czyżyk, M., & Friedman, A. (2014). Reproductive life characteristics in females affected with Parkinson’s disease and in healthy control subjects – a comparative study on the Polish population. Neurologia i Neurochirurgia Polska, 48(5), 322–327. https://doi.org/10.1016/j.pjnns.2014.08.004
Park, H., & Kim, K. (2021). Trends and Factors Associated with Oral Contraceptive Use among Korean Women. Healthcare, 9(10), 1386. https://doi.org/10.3390/healthcare9101386
Park, J.-H., Kim, D.-H., Kwon, D.-Y., Choi, M., Kim, S., Jung, J.-H., Park, Y.-G., & Han, K. (2019). Trends in the incidence and prevalence of Parkinson’s disease in Korea: A nationwide, population-based study | BMC Geriatrics | Full Text. BioMed Central, 320. https://bmcgeriatr.biomedcentral.com/articles/10.1186/s12877-019-1332-7
Rao, S. C., Li, Y., Lapin, B., Pattipati, S., Ghosh Galvelis, K., Naito, A., Gutierrez, N., Leal, T. P., Salim, A., Salles, P. A., De Leon, M., & Mata, I. F. (2023). Association of women-specific health factors in the severity of Parkinson’s disease. Npj Parkinson’s Disease, 9(1), Article 1. https://doi.org/10.1038/s41531-023-00524-x
Risks and Benefits of Hormone Replacement Therapy (hormone replacement therapy) on JSTOR. (1996). Retrieved February 20, 2024, from https://www.jstor.org/stable/25066175
Schneider, D. G., & Lauber, M. (2020). The Chi-Square Test. https://dlf.uzh.ch/openbooks/statisticsforlinguists/chapter/chi-square-test-significance-2/
Schumacher-Schuh, Artur Francisco, Bieger, A., Okunoye, O., Mok, K. Y., Lim, S.-Y., Bardien, S., Ahmad-Annuar, A., Santos-Lobato, B. L., Strelow, M. Z., Salama, M., Rao, S. C., Zewde, Y. Z., Dindayal, S., Azar, J., Prashanth, L. K., Rajan, R., Noyce, A. J., Okubadejo, N., Rizig, M., … Global Parkinson’s Genetics Program (GP2). (2022). Underrepresented Populations in Parkinson’s Genetics Research: Current Landscape and Future Directions. Movement Disorders: Official Journal of the Movement Disorder Society, 37(8), 1593–1604. https://doi.org/10.1002/mds.29126
Shirley Ryan AbilityLab. (2014, January 29). Parkinson’s Disease Questionnaire—39. Shirley Ryan AbilityLab. https://www.sralab.org/rehabilitation-measures/parkinsons-disease-questionnaire-39
Shulman, L. M. (2002). Is there a connection between estrogen and Parkinson’s disease? Parkinsonism & Related Disorders, 8(5), 289–295. https://doi.org/10.1016/s1353-8020(02)00014-7
Tenny, S., & Hoffman, M. R. (2024). Relative Risk. In StatPearls. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK430824/
The North American Menopause Society. (n.d.). Hormone Therapy: Benefits& Risks. The North American Menopause Society. Retrieved February 20, 2024, from https://www.menopause.org/for-women/menopauseflashes/menopause-symptoms-and-treatments/hormone-therapy-benefits-risks
Wang, P., Li, J., Shi, Q., Wen, H., & Du, J. (2014, December 31). Hormone replacement therapy and Parkinson’s disease risk in women: A meta-analysis of 14 observational studies—PMC. National Library of Medicine. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317144/
Yasui, M., Kihira, T., Ota, K., Funahashi, K., & Komai, N. (1992). [A case of parkinsonism induced by an oral contraceptive]. No to Shinkei = Brain and Nerve, 44(2), 163–166.
Yu, Z., Jiao, Y., Zhao, Y., & Gu, W. (2022, December 2). Level of Estrogen in Females—The Different Impacts at Different Life Stages. Multidisciplinary Digital Publishing Institute. https://www.mdpi.com/2075-4426/12/12/1995
Yuen, K. K. (1974). The Two-Sample Trimmed t for Unequal Population Variances. Biometrika, 61(1), 165–170. https://doi.org/10.2307/2334299
Yuk, J.-S., & Jeong, S. H. (2023). Association Between Menopausal Hormone Therapy and Risk for Parkinson’s Disease. Journal of Parkinson’s Disease, 13(8), 1357–1367. https://doi.org/10.3233/JParkinson's disease-230230
Zhao, Y. J., Wee, H. L., Chan, Y.-H., Seah, S. H., Au, W. L., Lau, L. N., Pica, E., Li, S. C., Luo, N., & Tan, L. (2010). Progression of Parkinson’s disease as evaluated by Hoehn and Yahr stage transition times—Zhao—2010—Movement Disorders—Wiley Online Library. 25(6), 710–716.
Published
How to Cite
Issue
Section
Copyright (c) 2024 Reyna Han; Dr. Kathryne Van Hedger
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
